According to the latest market report published by Credence Research, Inc. “Psoriasis Treatment Market - Growth, Future Prospects and Competitive Analysis, 2017 - 2025” the global Psoriasis Treatment market was valued at US$ 7.9 Bn in 2016, and is expected to reach US$ 12.8 Bn by 2025, expanding at a CAGR of 5.4% from 2017 to 2025.
Market Insights
Psoriasis is a chronic, inflammatory, painful skin disease for which there is no cure with great negative impact on patient’s quality of life. Primary goal of treatment is to reduce inflammation and to stop the skin cells from growing so quickly. Psoriasis treatment market is rapidly growing due to factors such as growing prevalence in some countries, significant unmet needs, promising pipeline molecules would drive the growth of psoriasis market worldwide. For the purpose of study, the global psoriasis treatment market is segmented on the basis of drug class such as TNF Inhibitors, Vitamin D analogs, interleukin blockers, and other psoriasis medications.
Browse Full Report Originally Published by Credence Research at https://www.credenceresearch.com/report/psoriasis-treatment-market
It is observed that, in the base year 2016, interleukin blockers is major revenue contributing segment due to its long-term safety with lower risk of infection and malignancy, furthermore newly approved Siliq (brodalumab) and Tremfya (Guselkumab) expected to drive significant market growth during forecast period. Psoriasis treatment market is categorized on the basis of type such plaque, guttate, flexural or inverse, psoriatic arthritis and others type, however, it is observed that plaque psoriasis is major revenue generating segment because it affects more than 70% of psoriasis patients. Psoriasis treatment market is currently dominated by North America, factors such as higher cost of therapy, a higher number of psoriasis patients, government reimbursement policies fueling the growth of psoriasis treatment market in North America. However, developing economic conditions and rising healthcare awareness would drive market growth during the forecast period.
Key Market Movements:
- Factors such as higher prevalence psoriasis disease, increasing treatment awareness, higher treatment compliance, and favorable reimbursement policies in some countries are driving the market growth of psoriasis treatment worldwide.
- Due to the high unmet needs, vendors in the market are focusing on the development of ideal treatment, promising pipeline molecule, rising access for the treatment medication in some developing countries, increase in the incidence of psoriasis and skin disorders would fuel the growth of psoriasis treatment market during forecast period.
- However, patent expiry of blockbuster drugs leads to generic erosion and adverse effects associated with the use of medication which would negatively impact the growth of psoriasis treatment market.
Access Free Sample Copy of Research Report: https://www.credenceresearch.com/sample-request/58469
List of Companies Covered:
- AbbVie Inc.
- Amgen Inc.
- AstraZeneca
- Biogen
- Boehringer Ingelheim
- Celgene
- Eli Lilly and Company
- Johnson & Johnson
- LEO Pharma A/S
- Merck & Co., Inc.
- Novartis AG
- Pfizer, Inc.
- Stiefel Laboratories Inc. (GlaxoSmithKline plc)
- Sun Pharmaceutical Industries
Market Segmentation
By Drug Class
- Interleukin Blockers
- Topical Corticosteroids
- Tumor Necrosis Factor (TNF) Inhibitors
- Vitamin D Analogues
- Others
By Type
- Plaque psoriasis
- Guttate psoriasis
- Flexural or inverse psoriasis
- Psoriatic arthritis
- Others
By Geography Segment Type
- North America (the U.S., Rest of North America)
- Europe (U.K., Germany, France, Rest of Europe)
- Asia Pacific (China, Japan, India, Rest of Asia Pacific)
- Rest of the World (the Middle East & Africa, Latin America)
Access Free Sample Copy of Research Report: https://www.credenceresearch.com/sample-request/58469
